Inauguration of the European Plotkin Institute for Vaccinology
On May 24th 2022, The European Plotkin Institute for Vaccinology was inaugurated at the Academy Palace in Brussels in the presence of Stanley and Susan Plotkin. On this occasion, the Université libre de Bruxelles and the Universiteit Antwerpen jointly awarded the degree of Doctor Honoris Causa to Professor Stanley Plotkin for his immense contribution to public health and humanity through the development of vaccines and the promotion of vaccination.
Combining vaccine trials and in-depth analyses of the immune system makes us better prepared to evaluate and help develop vaccines.
We have a long-standing experience in running (inter)national vaccine safety and efficacy and immunogenicity trials. Our institute is contributing to the development and evaluation of vaccines targeting epidemic and endemic pathogens.
Our scientists perform in-depth and systems analyses of immune responses to vaccines and pathogens. This knowledge combined with controlled human challenge studies will provide pivotal knowledge to help develop future vaccines.
The European Plotkin Institute for Vaccinology will be fully operational in the second quarter of 2022. We’ll work in our new, state-of-the-art facilities in Antwerp and Brussels.
Get in touch
Our insitute will be fully operational in the second quarter of 2022.
We are currently looking for sponsors and collaborators who want to support our academic research.